Financial Freedom LLC’s AbbVie ABBV Stock Holding History

Financial Freedom LLC’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-111	Closed	-$24.1K	–	110
2026 Q1	$24.1K	Hold	111	–	–	0.01%	219
2025 Q4	$25.3K	Hold	111	–	–	0.01%	206
2025 Q3	$25.7K	Hold	111	–	–	0.01%	210
2025 Q2	$20.6K	Buy	111 +1	+0.9%	+$186	0.01%	225
2025 Q1	$23K	Buy	110 +1	+0.9%	+$194	0.01%	220
2024 Q4	$19.3K	Buy	109 +1	+0.9%	+$184	0.01%	227
2024 Q3	$21.3K	Buy	108 +1	+0.9%	+$187	0.01%	217
2024 Q2	$18.4K	Buy	107 +1	+0.9%	+$166	0.01%	228
2024 Q1	$19.3K	Buy	106 +1	+1%	+$172	0.01%	229
2023 Q4	$16.3K	Buy	105 +1	+1%	+$146	0.01%	239
2023 Q3	$15.5K	Buy	104 +1	+1%	+$147	0.01%	244
2023 Q2	$13.9K	Buy	103 +1	+1%	+$147	0.01%	244
2023 Q1	$16.2K	Sell	102 -6	-6%	-$917	0.01%	227
2022 Q4	$17.4K	Buy	+108	New	+$16.6K	0.01%	222

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Financial Freedom LLC's ABBV Position: Q2 2026 in Review

Financial Freedom LLC sold out of AbbVie (ABBV) in Q2 2026, closing a stake of 111 shares — an estimated $24.1K sold.

Financial Freedom LLC first reported a position in ABBV in Q4 2022 and held it in 14 quarters. The position peaked at $25.7K in Q3 2025. 4,221 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Financial Freedom LLC reported no remaining AbbVie position as of Q2 2026 after selling out during the quarter.
Financial Freedom LLC sold 111 AbbVie shares in Q2 2026, an estimated $24.1K.
Financial Freedom LLC first reported a position in AbbVie in Q4 2022 and held it in 14 quarters.
Financial Freedom LLC's AbbVie position peaked at $25.7K in Q3 2025.
4,221 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Financial Freedom LLC's 13F filing for Q2 2026, filed 6 Aug 2026.